Seminars in Oncology

Papers
(The TQCC of Seminars in Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
TOC73
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis58
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance32
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review29
Editorial Board25
Role of neoadjuvant pembrolizumab in advanced melanoma21
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics21
Military exposures and lung cancer in United States Veterans16
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans14
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations14
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer14
Editorial Board13
Masthead13
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis13
The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review12
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review11
Liquid Biopsy, the hype vs. hope in molecular and clinical oncology11
Masthead10
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer10
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use10
Masthead10
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.10
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)9
Acute liver failure secondary to malignant infiltration: A single center experience9
Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran9
Barriers and facilitators to lung cancer screening and follow-up8
Editorial Board8
Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care8
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward8
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer8
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in t7
Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review7
Masthead7
Current and prospective antibody-based therapies in multiple myeloma6
outside front cover6
Radiation recall dermatitis: A review of the literature6
A narrative review of the principal glucocorticoids employed in cancer6
outside front cover6
Editorial Board6
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects6
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy6
Landmark trials in the medical oncology management of metastatic breast cancer5
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety5
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment5
Daratumumab: A review of current indications and future directions5
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data5
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty5
Masthead5
Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia5
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges5
0.28815507888794